novo nordisk cuts glp-1 drug prices for cash-paying customers. bets on lower to counter Lilly's Zepbound surge The maker of Ozempic is

doi:10.1016/j.regpep.2004.04.013 2022 The Author(s)

Other potential risks include gallbladder problems (including gallstones), kidney problems (particularly in patients with existing kidney disease who become dehydrated), and hypoglycemia when combined with other diabetes medications

If you are a female or male of reproductive potential: Discontinue Wegovy at least 2 months before a planned pregnancy since the drug can stay in the bloodstream for a long time

Beyond these company-specific decisions, the broader industry is converging around a range of improvements, including continuous manufacturing (replacing slower, batch-by-batch production), aqueous peptide synthesis (which reduces solvent dependency), advanced digital monitoring, and site automation

These can make treatment easier for those who need help controlling blood sugar levels both fasting and after meals